Product Launch

CAEVES Launches Context LAKE to Cut AI Token Costs by 47x

Image
CAEVES Launches Context LAKE to Cut AI Token Costs by 47x

New York – October 08, 2026 -- CAEVES Technology, Inc. will make its Context LAKETM platform generally available on October 08, 2026, extending AI data access beyond Microsoft Azure to any public, private, sovereign cloud, or on-premises datacenter environment.

Context LAKE cuts AI token consumption by up to 47 times in internal testing

CAEVES reports that its indexing and enrichment layer reduces the volume of raw content AI assistants must process per query, cutting token consumption by up to 47x and lowering associated AI token costs. Director of AI Innovation Kirk Ryan said the system allows an assistant to query once and retrieve the relevant passages with sources, rather than opening and paying to process file after file.

DoiT Partners With OpenAI to Track AI Spend on AWS

Image
DoiT Partners With OpenAI to Track AI Spend on AWS

Santa Clara, Calif. – October 08, 2026 -- DoiT has partnered with OpenAI to help enterprises move AI workloads from pilot to production on Amazon Web Services while tracing every dollar of spend to the customer, feature or agent that generated it.

Monthly AI spend among DoiT's customer base has surged roughly 100-fold in two years

Across DoiT's more than 4,000 customers, AI expenditure has outpaced the tools available to measure returns, pushing finance and engineering leaders to justify which models, features and customers are driving cost -- and whether each pays off.

DXC Expands Assure Platform, Tops 275 Insurer Customers

LONDON – October 08, 2026 -- DXC Technology (NYSE: DXC) has grown Assure Platform adoption to more than 275 customers as it rolls out new AI-enabled tools and London Market investments aimed at modernizing insurer operations without disrupting legacy systems.

DXC adds 18 Smart App customers in one year, reaching 450 insurers

Since launching Assure Smart Apps a year ago, DXC has signed 18 new Smart App customers supporting more than 450 insurers. The AI-enabled tools target underwriting, claims, broking, distribution and operations, letting insurers start with a single business priority and scale capabilities over time.

VA Taps CLEAR's Biometric ID Platform to Fight $186B Payment Fraud

Image
VA Taps CLEAR's Biometric ID Platform to Fight $186B Payment Fraud

New York – – October 08, 2026 -- The U.S. Department of Veterans Affairs has integrated CLEAR's secure identity platform, CLEAR1, into a pilot program designed to simplify account access for the nation's roughly 17 million living Veterans while combating fraud across federal benefit programs.

VA.gov sign-in now offers biometric verification via selfie

Veterans can now create or access their VA.gov account using CLEAR1, which combines biometrics, government-issued identification and trusted data sources to verify identity. After a one-time setup, future sign-ins require only a selfie, reducing reliance on traditional usernames and passwords. VA operates the largest integrated health care system in the country, serving 9.1 million enrolled Veterans annually, and VA.gov serves as the primary digital gateway to earned benefits and services.

Elsevier Adds 13 JAMA Journals to ClinicalKey AI Platform

Image
Elsevier Adds 13 JAMA Journals to ClinicalKey AI Platform

New York – October 08, 2026 -- Elsevier has signed a strategic content agreement with the JAMA Network to integrate full-text content and visuals from 13 JAMA journals into ClinicalKey AI, its clinical-grade AI workspace, giving clinicians access to more than half of the world's top 100 medical journals through the platform.

Agreement covers 13 JAMA Network titles including flagship journal and specialty publications

The deal brings all published full-text content and visuals from JAMA, JAMA Network Open, and 11 specialty journals -- JAMA Cardiology, JAMA Dermatology, JAMA Health Forum, JAMA Internal Medicine, JAMA Neurology, JAMA Oncology, JAMA Ophthalmology, JAMA Otolaryngology-Head & Neck Surgery, JAMA Pediatrics, JAMA Psychiatry and JAMA Surgery -- into the responses clinicians receive through ClinicalKey AI. Content is available to ClinicalKey AI customers immediately.

Lakewood-Amedex's Nu-8 Cuts E. coli Growth by 97% in UTI Model

Image
Lakewood-Amedex's Nu-8 Cuts E. coli Growth by 97% in UTI Model

Sarasota, Fla. – October 08, 2026 -- Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) reported that its Bisphosphocin compound Nu-8, delivered intravesically to rodents infected with E. coli, achieved up to 97% inhibition of bacterial growth using a 10% solution, against no effect in a vehicle control group.

Nu-8 targets drug-resistant bacteria linked to catheter-associated UTIs

The Bisphosphocin class has shown in vitro activity against a broad range of resistant bacteria common in urinary tract infections, including E. coli, K. pneumoniae, and P. aeruginosa, and against biofilm-forming organisms. Complicated UTIs, particularly catheter-associated urinary tract infections, are frequently driven by drug-resistant strains and biofilm formation, a persistent challenge for hospital infection control.

Edgescan Launches Atomic, an Autonomous AI Penetration-Testing Tool

Image
Edgescan Launches Atomic, an Autonomous AI Penetration-Testing Tool

Dublin – October 08, 2026 -- Edgescan has launched Edgescan Atomic, an autonomous penetration-testing capability built on agentic AI, designed to close the gap left by scheduled security assessments. The tool can run on top of Edgescan's existing continuous security platform or operate as a standalone agentic penetration-testing solution.

Atomic replaces fixed testing schedules with on-demand validation

Traditional penetration-testing programs rely on periodic, scheduled engagements, leaving organizations exposed between tests as application code changes and threats evolve. Edgescan Atomic allows security teams to launch autonomous testing immediately, using previous target metadata when available, with validation handled by an agentic team backed by human experts when required.

Whirl AI Launches Integrated Business Environment for Enterprise IT

Image
Whirl AI Launches Integrated Business Environment for Enterprise IT

San Francisco – October 08, 2026 -- Whirl AI unveiled the Integrated Business Environment (IBE), a new AI category built specifically for enterprise IT departments managing CRM, ERP, HRIS and ITSM systems.

Whirl AI targets the 'rediscovery tax' draining enterprise IT productivity

The company says IT teams currently rebuild system knowledge manually from configurations, metadata, integrations, custom code and tickets every time a business leader asks how a process works or what a change would break. This reactive cycle consumes most of IT's time, leaving little capacity for leading transformation initiatives.

Upbeat Launches Bluemag Pi, a RISC-V Flight Controller With Onboard AI

Image
Upbeat Launches Bluemag Pi, a RISC-V Flight Controller With Onboard AI

New Taipei City – October 08, 2026 -- Upbeat Technology launched the Bluemag Pi, a sensor-integrated flight controller combining real-time flight control with onboard AI inference, targeting long-endurance fixed-wing aircraft, commercial multirotor drones and unmanned surface vessels.

Dual-core RISC-V chip separates flight-critical tasks from AI processing

The board runs on Upbeat's UP301 system-on-chip, pairing SiFive's E3 and E2 RISC-V processor cores. One core handles time-critical flight control while the second manages communication, navigation and AI tasks, according to the company.

Vitamin Angels Data Shows Nutrition Supplement Adherence Gaps at Scale

Image
Vitamin Angels Data Shows Nutrition Supplement Adherence Gaps at Scale

Goleta, Calif. – October 08, 2026 -- Vitamin Angels presented new implementation research at the 2026 Micronutrient Forum Global Conference in Accra, Ghana, revealing a sharp gap between access to maternal nutrition supplements and actual completion of recommended courses. In Makueni County, Kenya, formative research found that while 93% of pregnant women surveyed received iron and folic acid supplementation, only 17% completed the recommended 180-day course, even as 95% of pregnant women and 96% of health providers backed multiple micronutrient supplementation (MMS).